ARCHIVES

FDA carries Action On Two Cancer Drugs Over To 1996

This article is from The Cancer Letter archive.

Vol. 22 No. 01 | January 5, 1996

Download PDF Visit The Full Archive

Related Articles

In Setback For Generics, Court Overturns FDA.

November 9, 2001

Information Branches Combined Under ICIC, Moved to Office Of NCI Deputy Director

November 23, 1997

Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin

October 17, 2014

First NCI Director To Resign Due To Presidential Election?

December 15, 2000

NCAB To Consider Fate Of Existing Two Proposed Comp Center At Important Meeting

April 28, 1978

Afinitor and Sutent Approved For Pancreatic Neuroendocrine Tumors

May 27, 2011